Skip to main content
. 2021 Feb 3;14:101–108. doi: 10.2147/JAA.S284813

Table 2.

Complementary Tests and Treatment

Pre-COVID-19 COVID-19 P
Complementary tests
 1. Chest Radiography 36 (24.7%) 5 (18.5%) 0.625
 2. Blood test 2 (1.4%) 0 (0%) 1
 3. Pharyngeal or nasopharyngeal culture 4 (2.7%) 1 (3.7%) 0.577
 4. SARS-CoV-2 PCR test 0 (0%) 1 (3.7%)
Treatment
1. Salbutamol <0.001
 Nebulizer 133 (84.2%) 7 (23.3%)
 Inhaler 5 (3.2%) 11 (36.7%)
 Direct at home 20 (12.7%) 12 (40%)
2. Ipratropium 78 (49.4%) 7 (23.3%) 0.009
3. Steroids 89 (56.3%) 18 (60%) 0.710
4. Antibiotic therapy 31 (19.6%) 7 (23.3%) 0.891
5. Respiratory support
 With respiratory support:

16 (10.1%)

2 (6.67%)

0.743
 Oxygen (nasal or Ventimask) 12 (7.59%) 2 (6.67%)
 OAF 4 (2.53%) 0 (0%)
 VNI/VM 0 (0%) 0 (0%)